Giant cell tumour of soft tissue causing oncogenic osteomalacia: report demonstrating the use of octreotide scintigraphy in tumour localization

Clinical Radiology

Volumn 63, Issue 1, 2008, Pages 101-107

  Harish, S ^a,b   Jurriaans, E ^a,b   Jan, E ^a,b   Sur, M ^a   Colterjohn, N ^a  

^a HENDERSON GENERAL HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GADOLINIUM; INDIUM 111; OCTREOTIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GIANT CELL TUMOR; HUMAN; OSTEOMALACIA; PRIORITY JOURNAL; SCINTIGRAPHY; SOFT TISSUE; TUMOR LOCALIZATION;

ADULT; GIANT CELL TUMORS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OCTREOTIDE; OSTEOMALACIA; PARANEOPLASTIC SYNDROMES; SOFT TISSUE NEOPLASMS;

EID: 36749024537     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2007.05.017     Document Type: Article

References (30)

1. Dodd L.G., Major N., and Brigman B. Malignant giant cell tumor of soft parts. Skeletal Radiol 33 (2004) 295-299
2. Oliveira A.M., Dei Tos A.P., Fletcher C.D., et al. Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol 24 (2000) 248-256
3. O'Connell J.X., Wehrli B.M., Nielsen G.P., et al. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors. Am J Surg Pathol 24 (2000) 386-395
4. Rodriguez-Peralto J.L., Lopez-Barea F., and Fernandez-Delgado J. Primary giant cell tumor of soft tissues similar to bone giant cell tumor: A case report and literature review. Pathol Int 51 (2001) 60-63
5. Folpe A.L., Morris R.J., and Weiss S.W. Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts. Mod Pathol 12 (1999) 894-902
6. Sundaram M., and McCarthy E.F. Oncogenic osteomalacia. Skeletal Radiol 29 (2000) 117-124
7. Carpenter T.O. Oncogenic osteomalacia-a complex dance of factors. N Engl J Med 348 (2003) 1705-1708
8. Folpe A.L., Fanburg-Smith J.C., Billings S.D., et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28 (2004) 1-30
9. Reis-Filho J.S., Paiva M.E., and Lopes J.M. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia. Arch Pathol Lab Med 126 (2002) 1245-1246
10. Ogose A., Hotta T., Emura I., et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol 30 (2001) 99-103
11. Nguyen B.D., and Wang E.A. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med 24 (1999) 130-131
12. Rhee Y., Lee J.D., Shin K.H., et al. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf) 54 (2001) 551-554
13. Moran M., and Paul A. Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia. Int Orthop 26 (2002) 61-62
14. Garcia C.A., and Spencer R.P. Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med 27 (2002) 582-583
15. Jan de Beur S.M., Streeten E.A., Civelek A.C., et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359 (2002) 761-763
16. Seufert J., Ebert K., Muller J., et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345 (2001) 1883-1888
17. Ryan E.A., and Reiss E. Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med 77 (1984) 501-512
18. Salm R., and Sissons H.A. Giant-cell tumours of soft tissues. J Pathol 107 (1972) 27-39
19. Teot L.A., O'Keefe R.J., Rosier R.N., et al. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. Hum Pathol 27 (1996) 625-632
20. Furco A., Roger M., Mouchet B., et al. Osteomalacia cured by surgery. Eur J Intern Med 13 (2002) 67-69
21. Edmister K.A., and Sundaram M. Oncogenic osteomalacia. Semin Musculoskelet Radiol 6 (2002) 191-196
22. Fukumoto S., Takeuchi Y., Nagano A., et al. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 25 (1999) 375-377
23. Avila N.A., Skarulis M., Rubino D.M., et al. Oncogenic osteomalacia: lesion detection by MR skeletal survey. AJR Am J Roentgenol 167 (1996) 343-345
24. Dissanayake A.M., Wilson J.L., Holdaway I.M., et al. Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J 33 (2003) 615-616
25. Jan de Beur S.M. Tumor-induced osteomalacia. JAMA 294 (2005) 1260-1267
26. Gonzalez-Compta X., Manos-Pujol M., Foglia-Fernandez M., et al. Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol 112 (1998) 389-392
27. Nelson A.E., Bligh R.C., Mirams M., et al. Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 88 (2003) 4088-4094
28. Paglia F., Dionisi S., and Minisola S. Octreotide for tumor-induced osteomalacia. N Engl J Med 346 (2002) 1748-1749
29. Schapira D., Ben Izhak O., Nachtigal A., et al. Tumor-induced osteomalacia. Semin Arthritis Rheum 25 (1995) 35-46
30. Park Y.K., Unni K.K., Beabout J.W., et al. Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions. J Korean Med Sci 9 (1994) 289-298